Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy

Abstract

Progress toward elucidating the function of α1B-adrenergic receptors (α1BARs) in the central nervous system has been constrained by a lack of agonists and antagonists with adequate α1B-specificity. We have obviated this constraint by generating transgenic mice engineered to overexpress either wild-type or constitutively active α1BARs in tissues that normally express the receptor, including the brain. All transgenic lines showed granulovacular neurodegeneration, beginning in α1B-expressing domains of the brain and progressing with age to encompass all areas. The degeneration was apoptotic and did not occur in non-transgenic mice. Correspondingly, transgenic mice showed an age-progressive hindlimb disorder that was parkinsonian-like, as demonstrated by rescue of the dysfunction by 3, 4-dihydroxyphenylalanine and considerable dopaminergic-neuronal degeneration in the substantia nigra. Transgenic mice also had a grand mal seizure disorder accompanied by a corresponding dysplasia and neurodegeneration of the cerebral cortex. Both behavioral phenotypes (locomotor impairment and seizure) could be partially rescued with the α1AR antagonist terazosin, indicating that α1AR signaling participated directly in the pathology. Our results indicate that overstimulation of α1BAR leads to apoptotic neurodegeneration with a corresponding multiple system atrophy indicative of Shy-Drager syndrome, a disease whose etiology is unknown.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: General characterization of transgenic mice.
Figure 2: Locomotor dysfunction phenotype in transgenic mice.
Figure 3: Seizure phenotype in transgenic mice.
Figure 4: Neurodegeneration at 10 months.
Figure 5: Neurodegeneration at 18–21 months of age.

Similar content being viewed by others

References

  1. Burt, A.M. in Textbook of Neuroanatomy 367–399 (W.B. Saunders, Philadelphia, 1993).

    Google Scholar 

  2. Zuscik, M.J., Piascik, M.T. & Perez, D.M. Cloning, cell-type specificity, and regulatory function of the mouse α1B-adrenergic receptor promoter. Mol. Pharmacol. 56, 1288–1297 (1999).

    Article  CAS  Google Scholar 

  3. Perez, D.M. et al. Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor. Mol. Pharmacol. 49, 112–122 (1996).

    CAS  PubMed  Google Scholar 

  4. Hwa, J., Gaivin, R.J., Porter, J.E. & Perez, D.M. Synergism of constitutive activity in α1-adrenergic receptor activation. Biochemistry 36, 633–639 (1997).

    Article  CAS  Google Scholar 

  5. Duteil, J. et al. Central α1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur.J.Pharmacol. 180, 49–58 (1990).

    Article  CAS  Google Scholar 

  6. Sirvio, J. & MacDonald, E. Central α 1-adrenoceptors: Their role in the modulation of attention and memory formation. Pharmacol. Ther. 83, 49–65 (1999).

    Article  CAS  Google Scholar 

  7. Ramarao, C.S. et al. Genomic organization and expression of the human α1B-adrenergic receptor. J. Biol. Chem. 267, 21936–21945 (1992).

    CAS  PubMed  Google Scholar 

  8. Haavik, J. & Toska, K. Tyrosine hydroxylase and Parkinson's disease. Mol. Neurobiol. 16, 285–309 (1998).

    Article  CAS  Google Scholar 

  9. Palacios, J.M., Hoyer, D. & Cortes, R. α1-Adrenoceptors in the mammalian brain: Similar pharmacology but different distribution in rodents and primates. Brain Res. 419, 65–75 (1987).

    Article  CAS  Google Scholar 

  10. Day, H.E.W., Campeau, S., Watson, S.J. Jr. & Akil, H. Expression of α1B adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J. Neurosci. 19, 10098–10106 (1999).

    Article  CAS  Google Scholar 

  11. Ivanov, A. & Aston-Jones, G. Extranuclear dendrites of locus coeruleus neurons: activation by glutamate and modulation of activity by alpha adrenoceptors. J. Neurophysiol. 74, 2427–2436 (1995).

    Article  CAS  Google Scholar 

  12. Kirkwood, A., Rozas, C., Kirkwood, J., Perez, F. & Bear, M.F. Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. J. Neurosci. 19, 1599–1609 (1999).

    Article  CAS  Google Scholar 

  13. Beani, L., Tanganelli, S., Antonelli, T. & Bianchi, C. Noradrenergic modulation of cortical acetylcholine release is both direct and γ-aminobutyric acid-mediated. J. Pharmacol. Exp. Ther. 236, 230–235 (1986).

    CAS  PubMed  Google Scholar 

  14. Frandsen, A. & Schousboe, A. Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons. J. Neurochem. 60, 1202–1211 (1993).

    Article  CAS  Google Scholar 

  15. Turner, P.R., Mefford, S., Christakos, S. & Nissenson, R.A. Apoptosis mediated by activation of the G-protein coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP). Mol. Endocrinol. 14, 241–254 (2000).

    Article  CAS  Google Scholar 

  16. Cash, R., Ruberg, M., Raisman, R. & Agid, Y. Adrenergic receptors in Parkinson's disease. Brain Res. 322, 269–275 (1984).

    Article  CAS  Google Scholar 

  17. Gioanni, Y., Thierry, A.-M., Glowinski, J. & Tassin, J.-P. α1-Adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: Implications for the modality of action of different types of neuroleptics. Synapse 30, 362–370 (1998).

    Article  CAS  Google Scholar 

  18. Baik, J.-H. et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424–428 (1995).

    Article  CAS  Google Scholar 

  19. Amabeoku, G. & Chandomba, R. Strychnine-induced seizures in mice: the role of noradrenaline. Prog. Neuropsychopharmacol. Biol. Psychiatry 18, 753–763 (1994).

    Article  CAS  Google Scholar 

  20. Briere, R. et al. α-1 Adrenoceptors are decreased in human epileptic foci. Ann. Neurol. 19, 26–30 (1985).

    Article  Google Scholar 

  21. Jazrawi, S.P. & Horton, R.W. Brain adrenoceptor binding sites in mice susceptible (DBA/2J) and resistant (C57 Bl/6) to audiogenic seizures. J. Neurochem. 47, 173–177 (1986).

    Article  CAS  Google Scholar 

  22. Milano, C.A., et al. Myocardial expression of a constitutively active a1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc.Natl.Acad.Sci.USA 91, 10109–10113 (1994).

    Article  CAS  Google Scholar 

  23. Akhter, S.A., et al. Transgenic mice with cardiac overexpression of a1B-adrenergic receptors. J.Biol.Chem. 272, 21253–21259 (1997).

    Article  CAS  Google Scholar 

  24. Cavalli, A., et al. Decreased blood pressure response in mice deficient of the a1b-adrenergic receptor. Proc.Natl.Acad.Sci.USA 94, 11589–11594 (1997).

    Article  CAS  Google Scholar 

  25. Sallinen, J., et al. Genetic alteration of a2C-adrenoceptor expression in mice: Influence on locomotor, hypothermic and neurochemical effects of dexmedetomidine, a subtype-nonselective a2-adrenoceptor agonist. Mol.Pharmacol. 51, 36–46 (1997).

    Article  CAS  Google Scholar 

  26. Hein, L., Limbird, L., Eglen, R.M. & Kobilka, B.K. Gene substitution/knockout to delineate the role of a2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines. Ann.N.Y.Acad.Sci. 881, 265–271 (1999).

    Article  CAS  Google Scholar 

  27. Fahn, S., Greene, P., Ford, B. & Bressman, S.B. Parkinsonism. In: Handbook of Movement Disorders 13–48 (Current Medicine, Inc., Philadelphia, PA, 1998).

    Google Scholar 

  28. Cotecchia, S., et al. Molecular cloning and expression of the cDNA for the hamster a1-adrenergic receptor. Proc.Natl.Acad.Sci.USA 85, 7159–7163 (1988).

    Article  CAS  Google Scholar 

  29. Domyancic, A.V. & Morilak, D.A. Distribution of a1A adrenergic receptor mRNA in the rat brain visualized by in situ hybridization. J.Comp.Neurol. 386, 358–378 (1997).

    Article  CAS  Google Scholar 

  30. Vince, D.G., et al. Quantitative comparison of immunohistochemical staining intensity in tissues fixed in formalin and Histochoice. Anal.Cell.Pathol. 15, 119–129 (1997).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank the Cleveland Clinic Foundation Transgenic Core for doing the transgene injections that produced founder mice. Histology and immunohistochemistry were done by G. Vince and M. Garcia of the Department of Biomedical Engineering at the Cleveland Clinic Foundation Lerner Research Institute. DNA was sequenced by the Cleveland Clinic Sequencing Core. This work was funded by RO1HL61438 (D.M.P.), F32HL1000402 (M.J.Z.), an American Heart Established Investigator Award (D.M.P.) and an unrestricted research grant from Glaxo Wellcome (D.M.P.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dianne M. Perez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zuscik, M., Sands, S., Ross, S. et al. Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy. Nat Med 6, 1388–1394 (2000). https://doi.org/10.1038/82207

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/82207

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing